Crystal structure of the therapeutic antibody binding fragment of gevokizumab in its unbound state


Domain Annotation: ECOD Classification ECOD Database Homepage

ChainsFamily NameDomain Identifier ArchitecturePossible HomologyHomologyTopologyFamilyProvenance Source (Version)
B [auth L]14-3-3e4g6kL1 A: alpha arraysX: beta-GraspH: Ubiquitin-relatedT: Ubiquitin-likeF: 14-3-3ECOD (v295.2)
A [auth H]Prenyltransfe4g6kH1 A: alpha arraysX: GIY-YIG endonucleaseH: GIY-YIG endonucleaseT: GIY-YIG endonucleaseF: PrenyltransfECOD (v295.2)

Domain Annotation: CATH CATH Database Homepage

ChainDomainClassArchitectureTopologyHomologyProvenance Source (Version)
B [auth L]2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (4.3.0)
A [auth H]2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (4.3.0)

IMGT Antibody Annotation IMGT Database Homepage

ChainProtein NameDescriptionOrganism NameGene Allele Name(s)Domain Name(s)Receptor TypeReceptor DescriptionProvenance Source
B [auth L]G1-derived gevokizumab Fab L-KAPPA Humanized, Chimeric IGKV1D-7-1*01, IGKJ2*01, IGKJ2*02, IGKC*01 V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA IG FAB-GAMMA-1_KAPPA IMGT (202633-0)
A [auth H]G1-derived gevokizumab Fab VH-CH1 Humanized, Chimeric IGHV8-4-12*01, IGHV8-4-8*01, IGHJ4*01, IGHG1*03, IGHG1*08, IGHG1*06, IGHG1*17 V-DOMAIN VH, C-DOMAIN CH1 IG FAB-GAMMA-1_KAPPA IMGT (202633-0)

SAbDab Antibody Annotation SAbDab Database Homepage

ChainChain ClassChain SubclassChain TypeAntigen Name(s) Provenance Source
B [auth L]Light ChainIGKV1 Kappa-SAbDab (2026-08-28)
A [auth H]Heavy ChainIGHV4 --SAbDab (2026-08-28)

Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage

ChainNameTargetProvenance Source
B [auth L] Gevokizumab IL1BTherapeutic SAbDab (2026-08-28)
A [auth H] Gevokizumab IL1BTherapeutic SAbDab (2026-08-28)